China's commitment to foster innovation and advance high-standard opening-up has provided global pharmaceutical companies ...

The country is also advancing the integration of TCM into modern healthcare by optimizing its clinical use and expanding ...

The largest of the collaborations is a potentially more than $4.68 billion partnership with Shanghai-based Harbour BioMed to discover and develop next-generation multi-specific antibodies for ...

Welcome to Maravai LifeSciences fourth quarter 2024 results earnings call. At this time, all participants are in a ...